Implementing artificial intelligence in breast cancer screening: Women's preferences.

Journal: Cancer
PMID:

Abstract

BACKGROUND: Artificial intelligence (AI) could improve accuracy and efficiency of breast cancer screening. However, many women distrust AI in health care, potentially jeopardizing breast cancer screening participation rates. The aim was to quantify community preferences for models of AI implementation within breast cancer screening.

Authors

  • Alison Pearce
    The Daffodil Centre, The University of Sydney, A Joint Venture With Cancer Council New South Wales, Sydney, New South Wales, Australia.
  • Stacy Carter
    Australian Centre for Health Engagement, Evidence and Values, School of Health and Society, University of Wollongong, Wollongong, New South Wales, Australia.
  • Helen Ml Frazer
    St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
  • Nehmat Houssami
    Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Mary Macheras-Magias
    Seat at the Table representative, Breast Cancer Network Australia, Camberwell, Victoria, Australia.
  • Genevieve Webb
    Health Consumers New South Wales, Sydney, New South Wales, Australia.
  • M Luke Marinovich
    The Daffodil Centre, The University of Sydney, A Joint Venture With Cancer Council New South Wales, Sydney, New South Wales, Australia.